LogicBio Therapeutics, Inc. Retained Earnings
LogicBio Therapeutics, Inc. had Retained Earnings of -$157.50 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-11-14
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$157.50M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$151.73M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$146.68M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$140.02M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-09-30 | -$157.50M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$151.73M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$146.68M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$140.02M 10-Q · filed 2022-11-14 |
| 2021-09-30 | -$130.96M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$120.77M 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$110.27M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$99.99M 10-K · filed 2022-03-04 |
| 2020-09-30 | -$93.09M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$85.05M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$76.83M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$67.37M 10-K · filed 2021-03-15 |
| 2019-09-30 | -$55.91M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$44.99M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$34.94M 10-Q · filed 2019-05-14 |
| 2018-12-31 | -$27.24M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$20.18M 10-Q · filed 2018-12-03 |
| 2017-12-31 | -$9.62M 10-K · filed 2019-04-01 |